UPDATED 12:05 p.m. Taking on a major securities fraud case growing out of the controversy over the pain medicine Vioxx, the Supreme Court agreed on Tuesday to clarify when an investor must go to court to make a fraud claim.  The Justices granted review of Merck & Co., et al., v. Reynolds, et al. (08-905).  … Continue reading Court to rule on Vioxx fraud case